Get facetime with leading pharma & biotech experts! Meet your 140+ 2019 speakers | - Jun Feng, Market Access Associate Director - Oncology, JAPAC, AbbVie,
Singapore
- Du Xin, Global Head of Regulatory Affairs, Adlai Nortye Biopharma, USA
- Ian Huen, CEO, Aptorum Group, Hong Kong, China
- Carl Firth, CEO, ASLAN Pharma, Singapore
- Harish Dave, Chief Medical Officer, AUM
Biosciences, Singapore
- Vishal Doshi, CEO, AUM Biosciences, Singapore
- Arani Chatterjee, Senior Vice President, Clinical Research, Aurobindo, India
- Vivian Bian, COO, BeiGene, China
- Amit Kumar,
Co-Founder & CEO, Biopsin, Singapore
- Dwo Yuan Sia, Chief Technology Officer, BravoVax, China
- Meng Chi Chen, Director, Business Development, BRIM Biotechnology, Taiwan
- Anthony Desir, Director, Cancelex, Hong Kong
- Nir
Arbel, Cofounder & CEO, Carmentix, Singapore
- Alexandre Civiere, Project Manager, Cell Prothera, Singapore
- Charles Stacey, CEO, Cerecin, Singapore
- Judy Walker, Chief Medical Officer, Cerecin, Singapore
-
Wei Jiang Goh, Co-Founder & CEO, Craft Health, Singapore
- Frank Jiang, CEO, CStone, China
- Stefan Glück, Vice President, Global Medical Affairs, Celgene, USA
- David Benshoof Klein, CEO and Founder, Click Therapeutics, USA
- Ed Rosen, Leader, Glendevon Life Sciences LLC, Executive in Residence, Columbia Technology Ventures, USA
- Ignacio Asial, Founder & CEO, DOTBIO, Singapore
- Pratapa S, Former Senior Director, Dr Reddy’s Laboratories, India
- Pei Yin Tan,
Director, Asia Clinical Operations, Medicine Development Center, Eisai Clinical Research, Singapore
| - Jeonghoon Han, Vice President Chief Development Officer and Chief Financial Officer, Eutilex, South Korea
- Marcel van Duin, Vice President, Therapeutic Area Head Reproductive Health & Endocrinology Research, Ferring Pharmaceuticals, Netherlands
- Carrie Hillyard, Chairman, Fitgenes, Australia
- Crystal Sun, Assistant CEO & Director, Regulatory & Government Affairs, Fosun Kite Biotechnology, China
- Sam Shen, QA Director, Fosun Kite Biotechnology Co.,Ltd., China
- TS Balganesh, President, Ganga Gen, India
- Qin Gang, President, GeneQuantum
Healthcare (Suzhou), China
- Hoon Seong, Deputy Manager, Genome & Company, South Korea
- Mahboob Rahman, Executive VP & Head, Clinical Sciences, Glenmark Pharmaceuticals, Singapore
- Maggie Lim, Director, Clinical Quality Assurance, Pharma R&D, APAC, Global Quality Assurance, R&D Chief Regulatory Office, GSK, Singapore
- Maijing Liao,
Senior Vice President, Head of Business Development and Portfolio Management, Harbour BioMed, China
- Mario Bertazzoli, Director, Group Head of Drug Safety, Helsinn Healthcare, Switzerland
- Jeffrey Dao, Operating Officer & Business Development Officer, HighTide Therapeutics, USA
- Yau Teng Yan, Chief Medical Officer, Holmusk, Singapore
- Piers Ingram, CEO,
Hummingbird Biosciences, Singapore
- Sabrina Ng, Chief Financial Officer, Hummingbird Biosciences, Singapore
- Maria Chen, Director, Business Development, Immunwork, Taiwan
- Wenzhi Tian, MD, Chairman, CEO, ImmuneOnco Biopharma, China
- Nick Ede, Chief Technology Officer, Imugene, Australia
- George Kopsidas,
Executive Director and Chief Scientific Officer, Imunexus, Australia
| - Anil Pareek, President, Medical Affairs and Clinical Research, IPCA, India
- Nathan Kothadaraman, Director, Market Access and Government Affairs, Janssen, Malaysia
- James Garner, CEO, Kazia Therapeutics,
Australia
- Chongdeok Park, Chief Development Officer, Kolon Pharmaceuticals, South Korea
- Dean Ho, Co – Founder, KYAN Therapeutics, Singapore
- Kamal Amin, Senior Clinical Supply Manager, Fujifilm Kyowa Kirin Biologics, UK
- Andreas Koester, Vice President, Clinical Trial Innovation & External Alliances, Janssen, J&J, USA
-
Vicky Han, Senior Director, Regulatory Policy Group Lead, Janssen, J&J, Singapore
- Victor Li, CEO, LionTCR, Singapore
- Antonio Bertoletti, Co-Founder, LionTCR, Singapore
- Ken Taylor, CEO, Living Cells Technologies, New Zealand
- Stephanie Liu, Medical,
Regulatory & Clinical Quality Assurance (MRC QA) Lead, Lundbeck, Singapore
- Gopal Rao, Global Business Development and Services Outsourcing, Lupin, India
- Antonio Lee, Global Head of Business Development, MEDIPOST, CEO & Managing Director, MEDIPOST AMERICA, South Korea
- Bechara Saab, CEO, Mobio Interactive, China
- Jason Widjaja, Associate
Director, Global Data Science (AI & Data Products), MSD, Singapore
- Dong-Hun Woo, Chief Operating & Technology Officer, Nexel, South Korea
- Kum Cheun (KC) Wong, Head of Asia Pacific, Regulatory and Development Policy, Novartis, Singapore
- Ogan Gurel, Founder & CEO, NovumWaves, South Korea
- Shwen Gwee,
General Manager, Digital Accelerator (Global Drug Development), Novartis, USA
| | - Xichen Lin, Research Director, Search & Evaluation, Novo Nordisk, China
- Jason Orbaugh, Director of Business Development, Path Therapeutics Inc, Canada
- Anand Gautam, Head of External Science & Innovation, Pfizer, Australia
-
Toru Seo, APAC Head, S&E, Worldwide Business Development, Chief Business Office, Pfizer, Japan
- Handsome Ji, APAC publishing lead, Pfizer, China
- Enver Erkan, Country Manager, Pfizer, Singapore
- Yuliana Indriati, President Director, PT Kalbe Genexine, Indonesia
- Mario Gattino, CEO, Respiri, Australia
-
Finny Liu, PDR APAC Regulatory Policy Lead, Roche, Singapore
- Hyejin Shin, Director, Group Leader, Clinical QA, Samsung Bioepis, South Korea
- Shailendra Bajpai, Global Head of Disease Management, Sanofi, Singapore
- Yong Ho Oh, Regional Clinical Project Manager, ISS Project Manager, Sanofi, Singapore
- Evelyn Pang,
Head of Operations, Sanofi Pasteur, Singapore
- Byung-Geon (BG) Rhee, CEO, SCM Lifesciences, Chairman, Council for Advanced Regenerative Medicine, Former President, Green Cross Corporation, South Korea
- Gloria Wang, Chief Medical Officer, Shanghai Sinobioway Sunterra Biotech, China
- Liping Liu, Founder, CEO& CSO, ShenZhen HighTide Biopharmaceuticals, China
-
John Patava, Global Head of Scientific Affairs, Sirtex Medical, Australia
- Raphael Aswin, Vice President R&D and Regulatory, SOHO Global Health, Indonesia
- Jeong Beom Kim, CEO, SuPine Therapeutics Co. Ltd, South Korea
- Philippe Pinton, Regional Head, Specialty Therapy, Takeda, Japan
- Susanne Weissbacker, Global Head of Access to Medicines, Takeda,
Singapore
- Aung Myo, Vice President, Clinical Development, Tessa Therapeutics, Singapore
- Josemund Menezes, Director, Medical Affairs & Clinical Development, Tessa Therapeutics, Singapore
- Alexander Kort, SVP Corporate Development, Themis Bioscience, Austria
- Seok Joong Kim, Board Member, Director and Head of Business Development, Toolgen, South Korea
|
- Younggyu Cho, Chief Technology Officer, Y-Biologics, South Korea
- Jang Woo Shin, Senior Principal Scientist, R&D Strategy & Planning Team, Yuhan R&D Institute, South Korea
- Robert Yu,
Senior Vice President, Operations, Yuyu Pharma, South Korea
- Billy Cho, CFO, Zai laboratories, China
- Abraham Cinta, CEO, ARC Capital, Singapore
- Gavin Teo, General Partner, B Capital, USA
- Sean Cao, Managing Director, C-Bridge Capital Partners LLC, USA
- Haolin Sung,
Director, Direct Investment Department, Diamond BioFund, Taiwan
- Sinclair Dunlop, Managing Director, Epidarex Capital, UK
- Xiangqian (XQ) Lin, Managing Partner, Esco Ventures, Singapore
- Ashish Patel, Head of Research, Investment Manager, Mercia Technologies PLC, UK
- Jeffry Wu, Managing Director, Milestone Capital, China
- Hironoshin
Nomura, Senior Analyst, Mizuho Securities, Japan
- Alfred Scheidegger, Partner& Founder, Nextech Invest, Switzerland
- Marietta Wu, Managing Partner, Quan Capital, China
- Joseph Mocanu, Managing Director, Verge Capital Management, Singapore
- Donald Xu, Managing Director, Lynx Financial, China
-
Atsushi Usami, Partner, University of Tokyo Edge Capital (U-TEC), Japan
- Sir David Lane, Chief Scientist, A*STAR, Singapore
- Mrunalini Jagtap, Data Management Lead, Singapore Institute for Clinical Sciences (SICS), A*STAR, Singapore
- Nathanael Faibis, CEO, Alodokter, Indonesia
- Nitin Jain
, VP Asia Pacific, Ancillare, Singapore
- Raghu Bathina, CEO, Celes Care, Founder, Future World Studios, India
- Lynne Baxter, Team Leader Clinical Study Research, Danone Nutriticia Research, Singapore
- Fiona Wong, Team Leader Clinical Studies ASPAC, Danone Nutriticia Research, Singapore
- Salah Uddin, Assistant
Director, Directorate General of Drug Administration, Bangladesh
- Reenita Das, Partner, Frost & Sullivan, USA
- Mohd Fazli Shuib, Head, Pharmacy Services, FV Hospital, Vietnam
- Sushant Sahastrabuddhe, Director, Enteric Fever, International Vaccine Institute, South Korea
|
- Andrew Gebbie, Principal Solution Consultant, Medidata Solutions, United Kingdom
- Aparajeeta Priyadarasini, Solution Consultant, Medidata Solutions, India
- Edwin Ng, Vice President, Field Operations, APeJ, Medidata Solutions, Singapore
- Ross Rothmeier, Vice President Tech Solutions, Medidata Solutions, USA
-
Keita Maeda, Deputy Director of Bio-Industry Division, Ministry of Economy, Trade and Industry (METI), Japan
- Phusit Prakongsai, Acting Senior Advisor, Health Promotion, Office of Permanent Secretary, Ministry of Public Health, Thailand
- Nadia Suttikulpanich, Head of Fuchsia Innovation Center, Muang Thai Life Assurance, Thailand
- Sophie Tsou, Associate Investigator, Division of Biostatistic and Bioinformatics, Institute of Population Health Sciences, National
Health Research Institute, Taiwan
- Matt Cooper, Business Development and Marketing Director, NIHR Clinical Research Network, UK
- Mayank Gurnani, Associate Professor, Industry Liaison Office, National University of Singapore, Singapore
- Teck Jack Tan, Chairman & Medical Director, Northeast Medical Group, Singapore
- Henry Ines, CEO, Project Shivom, USA
- JingPing Yeo, Director, Research Integrity, Compliance, Ethics, Singapore Health Services, Singapore
- Tong Hsien-Hui, Head, Venture Investing, SGInnovate, Singapore
- Poh Loong Soong, Founder & CEO, Ternion Biosciences, Singapore
- I-Ning Tang, Team Leader, Center of Consultation, Taiwan Center for Drug Evaluation, Taiwan
- Donna Collett,
Managing Partner, Valeur Consulting, Australia
- Chervee Ho, Director of Key Account Management Asia Pacific, Vetter Pharma International, Singapore
- Edmund Lim, Co-Founder and President, WeCareJourney, Malaysia
| | | |
오시는 길
로그인
회원가입
> 교육 및 행사 > 참가신청
